Opportunity ID: 339409

General Information

Document Type: Grants Notice
Funding Opportunity Number: PAR-22-149
Funding Opportunity Title: NEI Cooperative Agreement for Early-Stage Clinical Trials with Greater than Minimal Risk (U01 Clinical Trial Required)
Opportunity Category: Discretionary
Opportunity Category Explanation:
Funding Instrument Type: Cooperative Agreement
Category of Funding Activity: Health
Category Explanation:
Expected Number of Awards:
Assistance Listings: 93.867 — Vision Research
Cost Sharing or Matching Requirement: No
Version: Synopsis 1
Posted Date: Apr 12, 2022
Last Updated Date: Apr 12, 2022
Original Closing Date for Applications: May 07, 2025
Current Closing Date for Applications: May 07, 2025
Archive Date: Jun 12, 2025
Estimated Total Program Funding:
Award Ceiling:
Award Floor:

Eligibility

Eligible Applicants: Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education
Small businesses
State governments
Native American tribal organizations (other than Federally recognized tribal governments)
Public and State controlled institutions of higher education
Public housing authorities/Indian housing authorities
Others (see text field entitled “Additional Information on Eligibility” for clarification)
City or township governments
Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education
Special district governments
County governments
Independent school districts
Native American tribal governments (Federally recognized)
For profit organizations other than small businesses
Private institutions of higher education
Additional Information on Eligibility: Other Eligible Applicants include the following: Alaska Native and Native Hawaiian Serving Institutions; Asian American Native American Pacific Islander Serving Institutions (AANAPISISs); Eligible Agencies of the Federal Government; Faith-based or Community-based Organizations; Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Indian/Native American Tribal Governments (Other than Federally Recognized); Non-domestic (non-U.S.) Entities (Foreign Organizations); Regional Organizations; Tribally Controlled Colleges and Universities (TCCUs) ; U.S. Territory or Possession.

Additional Information

Agency Name: National Institutes of Health
Description: The NEI uses U01 cooperative agreement awards to support investigator-initiated early-stage clinical trials that are greater than minimal risk and typically are Phase I or II trials. The risk level of the U01 trial requires appropriate performance oversight and safety monitoring. For purposes of this FOA, the proposed study must be intended to evaluate interventions aimed at screening, diagnosing, preventing, or treating vision disorders.
Link to Additional Information: http://grants.nih.gov/grants/guide/pa-files/PAR-22-149.html
Grantor Contact Information: If you have difficulty accessing the full announcement electronically, please contact:

NIH OER Webmaster
OERWebmaster03@od.nih.gov
Email:OERWebmaster03@od.nih.gov

Version History

Version Modification Description Updated Date

Folder 339409 Full Announcement-PAR-22-149 -> PAR-22-149-Full-Announcement.pdf

Packages

Agency Contact Information: NIH OER Webmaster
OERWebmaster03@od.nih.gov
Email: OERWebmaster03@od.nih.gov
Who Can Apply: Organization Applicants

Assistance Listing Number Competition ID Competition Title Opportunity Package ID Opening Date Closing Date Actions
FORMS-G Use for due dates on or before January 24, 2023 PKG00273274 Apr 24, 2022 Jan 24, 2023 View
FORMS-H Use for due dates on or before January 24, 2025 PKG00277961 Nov 04, 2022 Jan 24, 2025 View
FORMS-I Use for due dates on or after January 25, 2025 PKG00289208 Nov 27, 2024 May 07, 2025 View

Package 1

Mandatory forms

339409 RR_SF424_5_0-5.0.pdf

339409 PHS398_CoverPageSupplement_5_0-5.0.pdf

339409 RR_OtherProjectInfo_1_4-1.4.pdf

339409 PerformanceSite_4_0-4.0.pdf

339409 RR_KeyPersonExpanded_4_0-4.0.pdf

339409 PHS398_ResearchPlan_4_0-4.0.pdf

339409 PHSHumanSubjectsAndClinicalTrialsInfo_3_0-3.0.pdf

Optional forms

339409 RR_Budget_3_0-3.0.pdf

339409 RR_SubawardBudget30_3_0-3.0.pdf

339409 PHS398_ModularBudget_1_2-1.2.pdf

339409 PHS_AssignmentRequestForm_3_0-3.0.pdf

Package 2

Mandatory forms

339409 RR_SF424_5_0-5.0.pdf

339409 PHS398_CoverPageSupplement_5_0-5.0.pdf

339409 RR_OtherProjectInfo_1_4-1.4.pdf

339409 PerformanceSite_4_0-4.0.pdf

339409 RR_KeyPersonExpanded_4_0-4.0.pdf

339409 PHS398_ResearchPlan_5_0-5.0.pdf

339409 PHSHumanSubjectsAndClinicalTrialsInfo_3_0-3.0.pdf

Optional forms

339409 RR_Budget_3_0-3.0.pdf

339409 RR_SubawardBudget30_3_0-3.0.pdf

339409 PHS398_ModularBudget_1_2-1.2.pdf

339409 PHS_AssignmentRequestForm_3_0-3.0.pdf

Package 3

Mandatory forms

339409 RR_SF424_5_0-5.0.pdf

339409 PHS398_CoverPageSupplement_5_0-5.0.pdf

339409 RR_OtherProjectInfo_1_4-1.4.pdf

339409 PerformanceSite_4_0-4.0.pdf

339409 RR_KeyPersonExpanded_4_0-4.0.pdf

339409 PHS398_ResearchPlan_5_0-5.0.pdf

339409 PHSHumanSubjectsAndClinicalTrialsInfo_3_0-3.0.pdf

Optional forms

339409 RR_Budget_3_0-3.0.pdf

339409 RR_SubawardBudget30_3_0-3.0.pdf

339409 PHS398_ModularBudget_1_2-1.2.pdf

339409 PHS_AssignmentRequestForm_4_0-4.0.pdf

2025-07-13T02:10:35-05:00

Share This Post, Choose Your Platform!

About the Author: